Werewolf Therapeutics

(NASDAQ) HOWL

Current Price$0.39

Market Cap$20.90M

Since IPO (2021)-97%

5 Year-97%

1 Year-68%

1 Month-40%

Werewolf Therapeutics Financials at a Glance

Market Cap

$20.90M

Revenue (TTM)

$0.00

Net Income (TTM)

-$56.27M

EPS (TTM)

-$1.21

P/E Ratio

-0.35

Dividend

$0.00

Beta (Volatility)

1.50 (High)

Dividend

$0.00

Beta (Volatility)

1.50 (High)

Price

$0.39

Volume

580,539

Open

$0.45

Price

$0.39

Volume

580,539

Open

$0.45

Previous Close

$0.39

Daily Range

$0.39 - $0.45

52-Week Range

$0.39 - $2.38

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.50 (High)

Price

$0.39

Volume

580,539

Open

$0.45

Previous Close

$0.39

Daily Range

$0.39 - $0.45

52-Week Range

$0.39 - $2.38

Estimated Earnings Date

Aug 6, 2026

HOWL News

Werewolf Reports No Revenue in Fiscal Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Werewolf Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Dan Hicklin, PhD

Website

www.werewolftx.com

Headquarters

Watertown, MA 02138, US

HOWL Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-162%

Return on Capital

-3%

Return on Assets

-97%

Earnings Yield

-2.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.90M

Shares Outstanding

48.60M

Volume

580.54K

Avg. Volume

454.61K

Financials (TTM)

Gross Profit

-$1.63M

Operating Income

-$60.68M

EBITDA

-$59.04M

Operating Cash Flow

-$60.29M

Capital Expenditure

$0.00

Free Cash Flow

-$60.29M

Cash & ST Invst.

$57.95M

Total Debt

$9.44M

Werewolf Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$398.00K

+6.6%

Gross Margin

0.00%

N/A

Market Cap

$20.90M

N/A

Market Cap/Employee

$454.27K

N/A

Employees

N/A

Net Income

-$13.53M

+25.2%

EBITDA

-$8.57M

+47.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$8.80M

-84.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$7.22M

-79.7%

Short Term Debt

$30.44M

+2055.5%

Return on Assets

-96.97%

N/A

Return on Invested Capital

-2.65%

N/A

Free Cash Flow

-$10.60M

+44.1%

Operating Cash Flow

-$10.60M

+44.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LITSLite Strategy, Inc.

LITSLite Strategy, Inc.$0.75-13.35%

OTLKOutlook Therapeutics, Inc.

OTLKOutlook Therapeutics, Inc.$0.78-2.28%

INMBINmune Bio, Inc.

INMBINmune Bio, Inc.$1.26-6.67%

IOBTIO Biotech, Inc.

IOBTIO Biotech, Inc.$0.01-27.59%

ACETAdicet Bio, Inc.

ACETAdicet Bio, Inc.$7.26-10.92%

SPRBSpruce Biosciences, Inc.

SPRBSpruce Biosciences, Inc.$50.43-5.15%

NRXPNRx Pharmaceuticals, Inc.

NRXPNRx Pharmaceuticals, Inc.$4.14+2.22%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About HOWL

What is the current price of Werewolf Therapeutics?

Werewolf Therapeutics is trading at $0.39 per share.

What is the 52-week range for Werewolf Therapeutics?

Over the past 52 weeks, Werewolf Therapeutics has traded between $0.39 and $2.38.

How much debt does Werewolf Therapeutics have?

As of the most recent reporting period, Werewolf Therapeutics reported total debt of $37.65M.

How much cash does Werewolf Therapeutics have on hand?

Werewolf Therapeutics reported $46.45M in cash and cash equivalents in its most recent financial results.

What is Werewolf Therapeutics’s dividend yield?

Werewolf Therapeutics does not currently have a dividend yield.

Werewolf Therapeutics

Werewolf Therapeutics Financials at a Glance

HOWL News

Werewolf Reports No Revenue in Fiscal Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Werewolf Therapeutics

HOWL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Werewolf Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HOWL

What is the current price of Werewolf Therapeutics?

What is the 52-week range for Werewolf Therapeutics?

How much debt does Werewolf Therapeutics have?

How much cash does Werewolf Therapeutics have on hand?

What is Werewolf Therapeutics’s dividend yield?

Premium Investing Services